跳至主要内容
临床试验/JPRN-UMIN000013419
JPRN-UMIN000013419尚未招募1 期

Clinical trial for recurrent malignant gliomas using boron neutron capture therapy and bevacizumab - BNCT plus bevacizumab for recurrent malignant gliomas

Dept. of Neurosurgery, Osaka Medical College0 个研究点目标入组 50 人开始时间: 2014年3月14日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
10years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Female patients in definitive or possible pregnancy or in breast-feeding. 2) Patients with phenylketonuria. 3) Patients with grade 3 or 4 in NYHA classification. 4) Patients with cerebrospinal fluid dissemination. 5) Other patients whose participation in the present study is considered inappropriate by a Principal Investigator or Clinical Investigator.

研究者

发起方
Dept. of Neurosurgery, Osaka Medical College

相似试验